Applied Therapeutics, Inc. (APLT)
Feb 3, 2026 - APLT was delisted (reason: acquired by Cycle Pharmaceuticals)
0.1030
0.00 (0.00%)
Inactive · Last trade price on Feb 2, 2026
Applied Therapeutics Stock Forecast
APLT's stock price has decreased by -82.44% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Applied Therapeutics stock had an average target of $1.25, with a low estimate of $1.00 and a high estimate of $1.50.
Price Target: $1.25 (+1,113.59%)
Analyst Consensus: Hold
Price Target
Analyst Ratings
The average analyst rating for Applied Therapeutics stock from 2 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
No data available
| Rating | Oct 2026 |
|---|---|
| Strong Buy | n/a |
| Buy | n/a |
| Hold | n/a |
| Sell | n/a |
| Strong Sell | n/a |
| Total | n/a |
Financial Forecast
Revenue This Year
1.02M
from 455.00K
Increased by 124.18%
Revenue Next Year
1.28M
from 1.02M
Increased by 25.00%
EPS This Year
-0.54
from -0.76
EPS Next Year
-0.44
from -0.54
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.1M | 5.3M | ||||
| Avg | 1.0M | 1.3M | ||||
| Low | 980,000 | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 130.8% | 414.7% | ||||
| Avg | 124.2% | 25.0% | ||||
| Low | 115.4% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.49 | -0.30 | ||||
| Avg | -0.54 | -0.44 | ||||
| Low | -0.61 | -0.50 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |